Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 21.31M P/E - EPS this Y 25.30% Ern Qtrly Grth -
Income -115.09M Forward P/E -0.47 EPS next Y 7.70% 50D Avg Chg -40.00%
Sales 9.75M PEG -0.01 EPS past 5Y - 200D Avg Chg -80.00%
Dividend N/A Price/Book 2.01 EPS next 5Y 75.00% 52W High Chg -92.00%
Recommedations 1.80 Quick Ratio 4.25 Shares Outstanding 112.05M 52W Low Chg 42.00%
Insider Own 1.19% ROA -75.02% Shares Float 66.85M Beta 1.46
Inst Own 47.01% ROE -151.98% Shares Shorted/Prior 2.54M/1.57M Price 0.22
Gross Margin 100.00% Profit Margin - Avg. Volume 3,013,331 Target Price 2.38
Oper. Margin -1,171.62% Earnings Date May 10 Volume 3,653,034 Change 1.95%
Calithera Biosciences, Inc. News
06:00 AM Calithera to Present at the H.C. Wainwright Global Investment Conference
05/10/22 Calithera Biosciences Reports First Quarter 2022 Financial Results and Recent Highlights
05/03/22 Calithera Biosciences to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022
04/08/22 Calithera Presents Data Highlighting Discovery of Novel Series of Promising Synthetic Lethal Compounds
04/01/22 Calithera Biosciences (CALA) Q4 2021 Earnings Call Transcript
03/31/22 Calithera Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
03/30/22 Calithera Biosciences Raises $10M Via Equity Issued At 10% Discount
03/30/22 Calithera Biosciences, Inc. Prices $10.0 Million Underwritten Public Offering of Common Stock and Warrants to Purchase Common Stock
03/29/22 Calithera Biosciences, Inc. Announces Commencement of Underwritten Public Offering of Common Stock and Warrants to Purchase Common Stock
03/24/22 Calithera Biosciences to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 31, 2022
03/08/22 Calithera to Present Data Highlighting Newly Discovered Synthetic Lethal Target VPS4 at AACR 2022 Annual Meeting
02/16/22 Calithera to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
01/20/22 Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
01/07/22 AN2 Therapeutics Closed $80 Million Series B Financing to Advance Novel Nontuberculous Mycobacterial Lung Disease Program
01/05/22 Calithera to Present at the H.C. Wainwright BioConnect Virtual Conference
12/24/21 Great news for Calithera Biosciences, Inc. (NASDAQ:CALA): Insiders acquired stock in large numbers last year
11/29/21 Do Options Traders Know Something About Calithera Biosciences (CALA) Stock We Don't?
11/12/21 Calithera to Present at the 2021 Jefferies London Healthcare Conference
11/11/21 Calithera Biosciences Insider Trades $170K In Company Stock

Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginase inhibitor that has completed Phase 1b clinical trial for the treatment of cystic fibrosis and chronic airway infection; and ATG-037, an orally-bioavailable small molecule inhibitor of CD73, as well as CB-668, an orally administered inhibitor of the enzyme IL4I1. The company has a license agreement with Mars, Inc. to develop and commercialize Symbioscience's portfolio of arginase inhibitors for use in human healthcare. It also has clinical trial collaboration with Pfizer to evaluate Pfizer's PARP inhibitor talazoparib and CDK4/6 inhibitor palbociclib, each in combination with telaglenasta. In addition, the company has a collaboration and license agreement with Incyte Corporation for the research, development, and commercialization of INCB001158, a small molecule arginase inhibitor for the treatment of hematology and oncology; and a license agreement with Antengene Corporation Ltd. for the development and commercialization of CB-708. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

CALA Chatroom

User Image trade4fun1 Posted - 32 minutes ago

$CALA .22 can't break .19 to .22 range

User Image bullerthanyou Posted - 1 hour ago

$CALA think this runs hard soon💡

User Image RFCAPITAL Posted - 2 hours ago

$CALA this will breakout soon!! No question about it , small float and ph2 initiation news coming soon

User Image Reydiy Posted - 2 hours ago

$CALA first PT .39 🎯

User Image Reydiy Posted - 2 hours ago

$CALA time to break .23 .. let’s go baby

User Image Reydiy Posted - 3 hours ago

$CALA bring that ask below .22 let me fill more

User Image PieBou67 Posted - 3 hours ago

$CALA Liftoff 🚀🚀🚀

User Image Reydiy Posted - 3 hours ago

$CALA next 4 hour leg is going to test above that .26 to .27

User Image Stockboi_ Posted - 3 hours ago

$CALA ok CALA wtf do you wanna do. No position. Need pull back for the risk reward to make sense imo.

User Image Reydiy Posted - 3 hours ago

$CALA .23 HOD break coming

User Image Reydiy Posted - 3 hours ago

$CALA .2661 break .. we will test .35 to .40s

User Image Reydiy Posted - 3 hours ago

$CALA volume pouring in

User Image Reydiy Posted - 3 hours ago

$CALA take it above .22 now

User Image Zap_Trades Posted - 3 hours ago

Midday Penny stock Watchlist $GFAI $CALA $MYSZ $IMMP $AUVI.

User Image Warlord2580 Posted - 4 hours ago

174 $1.00 bid rule deficient stocks are trying to regain Nasdaq compliance. Do you know which ones they are? The first link is to the Nasdaq Non-compliant companies list, updated daily. Here you can see which stocks are deficient, their deficiency, and the date the company was notified. The second link is to the SEC filings page I use. Search your stocks SEC filings from around the date the company was notified to read about the deficiency and date It must be corrected. https://listingcenter.nasdaq.com/noncompliantcompanylist.aspx https://www.sec.gov/edgar/searchedgar/companysearch.html $CLBS $CALA $CASI $CBIO $CLRB 6

User Image Reydiy Posted - 5 hours ago

$CALA @BottomFishingCharts @ProfessorDman1 i think this is ready

User Image Reydiy Posted - 5 hours ago

$CALA watch this above .25 today

User Image po3torrealba Posted - 6 hours ago

$CALA Lets go!!!

User Image Reydiy Posted - 6 hours ago

$CALA added .22

User Image shortablestocks Posted - 7 hours ago

$CALA is short sale restricted for 2022-05-17. https://www.shortablestocks.com/?CALA

User Image po3torrealba Posted - 8 hours ago

$CALA dump continuation today. Likely break into the teens again.

User Image Stonkmoon Posted - 9 hours ago

$CALA 2022-05-17 07:00 ET Calithera to Present at the H.C. Wainwright Global Investment Conference Calithera Biosciences, Inc. https://stonkmoon.com/news/CALA/6719ff8631c07ab0f2535ed49bbf7b57

User Image STCKPRO Posted - 9 hours ago

$CALA NEW ARTICLE : Calithera to Present at the H.C. Wainwright Global Investment Conference https://www.stck.pro/news/CALA/27868441

User Image Quantisnow Posted - 9 hours ago

$CALA 📰 Calithera to Present at the H.C. Wainwright Global Investment Conference https://quantisnow.com/i/2899447?utm_source=stocktwits 45 seconds delayed.

User Image Stock_Titan Posted - 9 hours ago

$CALA Calithera to Present at the H.C. Wainwright Global Investment Conference https://www.stocktitan.net/news/CALA/calithera-to-present-at-the-h-c-wainwright-global-investment-duax7qvwfu0a.html

User Image Newsfilter Posted - 9 hours ago

$CALA Calithera to Present at the H.C. Wainwright Global Investment Conference https://newsfilter.io/a/d246fa006dc3324768bf96f7944ffb5a

User Image RFCAPITAL Posted - 20 hours ago

$CALA I am the leader here, emailed company and have not received any response yet ! Need ph2 initiation news guys, we will come out strong! It’s a tough market so just diamond hands like $GME and $AMC apes if we wana come out alive !!

User Image RFCAPITAL Posted - 22 hours ago

$CALA here is my position hos , not selling until I die!!!

User Image tickeron Posted - 23 hours ago

Oh wow this is big! $CALA in Uptrend: price may jump up because it broke its lower Bollinger Band on May 11, 2022. View odds for this and other indicators: https://srnk.us/go/3669653

User Image steve_mason009 Posted - 23 hours ago

$CALA Boy, oh boy, some shit stories never going to change.

Analyst Ratings
SVB Leerink Outperform Apr 4, 22
Ladenburg Thalmann Buy Jan 31, 22
SVB Leerink Outperform Jan 20, 22
HC Wainwright & Co. Neutral Nov 8, 21
William Blair Market Perform Nov 5, 21
HC Wainwright & Co. Buy Jan 5, 21
SVB Leerink Market Perform Jan 5, 21
SVB Leerink Outperform Aug 11, 20
HC Wainwright & Co. Buy May 8, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Orford Keith Director Director Nov 05 Sell 0.84 51,810 43,520 144,284 11/09/21